How Ph.D. was paid
$2.8M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Jay R. Luly, Ph.D.President and Chief Executive Officer | $803,300 | $128,550 | $1,223,975 | $591,665 | $22,058 | $2,769,548 |
| Scott T. Rottinghaus, M.D.Chief Medical Officer | $560,300 | $53,563 | $425,943 | $281,348 | $22,058 | $1,343,212 |
| Yat Sun Or, Ph.D.Chief Scientific Officer | $553,150 | $53,563 | $425,943 | $239,374 | $21,761 | $1,293,790 |
What changed and why
- $2.8MCEO total compensation increased to $2,769,548 in fiscal 2025 compared to $2,695,276 in fiscal 2024.
- Stock awards include performance share units and relative total stockholder return units valued at grant date fair value.
- $1.2MOption awards for the CEO were valued at $1,223,975 using the Black-Scholes model.
- Non-equity incentive plan compensation reflects a prorated blend of variable cash compensation based on calendar year performance.
- 93%Say-on-pay received approximately 93% support at the previous annual meeting of stockholders.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.